1. Tanis B, Clavel M, Guastalla J,et al.: Phase I study of gemcitabine (diFluorodeoxycytidine; dFdC; (LY188011) administered in a two-weekly schedule. Proc AACR 31: 1230, 1990
2. Brown T, O'Rourke T, Burris H,et al.: A phase I trial of gemcitabine (LY188011) administered IV every two weeks. Proc ASCO 10: 328, 1991
3. O'Rourke T, Brown T, Havlin K,et al.: Phase I trial and immunologie assessment of difluorodeoxycytidine. Proc ASCO 8: 320, 1989
4. Casper CS, Green MR, Brown TD,et al.: Phase II trial of gemcitabine (2?2?-difluorodeoxycytidine) in patients with pancreatic cancer. Proc ASCO 10: 440, 1991
5. Anderson H, Lund B, Hansen HH,et al.: Phase II study of gemcitabine in non small cell lung cancer (NSCLC). Proc ASCO 10: 848, 1991